2nd Quarter - Amendment

340B HEALTH for 340B HEALTH

Firm
Client
Income
—
Expenses
$212,737
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Amendment Jul 20, 2009 $212,737 Replaced
2nd Quarter - Amendment (this page) Jun 10, 2010 $212,737 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

HR 444; S 1239; Health Care Reform Legislation Extending 340B Drug Pricing to Inpatient Setting in DSH Hospitals and improving program integrity. Preserving current 340B Patient Definition. Opposition to new regulations regarding physician administered drugs

LobbyistCovered position, as disclosed
VICTORIA AUFIERO —
STUART YAEL GORDON —
ROBERT RECKLAUS Chief of Staff for Carolyn McCarthy (02-08)
TED SLAFSKY Fellow for Sen. Democratic Policy Committee
JAIMIE VICKERY LA for Reps Horn and Biggest
WILLIAM VON OEHSEN —
BONNIE WEINTRAUB —

Contacted: HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); SENATE; Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 444 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.